A Multicenter, Randomized, Double-blind, Placebocontrolled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72- associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
- Rowe, Dominic (Primary Chief Investigator)
- Gan, Richard (Research Coordinator)
- Ordonez Artunduaga, Paula (Research Coordinator)
Project: Research